Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)

Historic Non-Current Deferred Tax Liability for cbdMD (YCBD) over the last 6 years, with Q3 2021 value amounting to $6.1 million.

  • cbdMD's Non-Current Deferred Tax Liability rose 58335.2% to $6.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $6.1 million, marking a year-over-year increase of 58335.2%. This contributed to the annual value of $6.1 million for FY2021, which is 58335.2% up from last year.
  • Latest data reveals that cbdMD reported Non-Current Deferred Tax Liability of $6.1 million as of Q3 2021, which was up 58335.2% from $130000.0 recorded in Q2 2021.
  • In the past 5 years, cbdMD's Non-Current Deferred Tax Liability ranged from a high of $6.1 million in Q3 2021 and a low of $15000.0 during Q4 2017
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $563000.0 (2020), whereas its average is $2.0 million.
  • Per our database at Business Quant, cbdMD's Non-Current Deferred Tax Liability soared by 3320666.67% in 2018 and then crashed by 8333.02% in 2020.
  • cbdMD's Non-Current Deferred Tax Liability (Quarter) stood at $15000.0 in 2017, then soared by 33206.67% to $5.0 million in 2018, then rose by 7.47% to $5.4 million in 2019, then crashed by 89.51% to $563000.0 in 2020, then skyrocketed by 986.32% to $6.1 million in 2021.
  • Its Non-Current Deferred Tax Liability was $6.1 million in Q3 2021, compared to $130000.0 in Q2 2021 and $27000.0 in Q1 2021.